Alexander Hann is performing clinical and basic research focusing on pancreatic cancer since his first year as a Physician. His career has been started in 2009 at the University Hospital Marburg, Germany, were he studied the molecular mechanisms of pancreatic cancer. During his stay at the Katharinen Hospital Stuttgart, Germany, from 2011 to 2015 he extended his research work to clinical studies. His main focus is on the application of new chemotherapeutic approaches and the resulting survival benefit. Since 2015, he continued his wok involving clinical and basic research at the University Hospital Ulm, Germany. Alexand Alexander Hann is performing clinical and basic research focusing on pancreatic cancer since his first year as a Physician. His career has been started in 2009 at the University Hospital Marburg, Germany, were he studied the molecular mechanisms of pancreatic cancer. During his stay at the Katharinen Hospital Stuttgart, Germany, from 2011 to 2015 he extended his research work to clinical studies. His main focus is on the application of new chemotherapeutic approaches and the resulting survival benefit. Since 2015, he continued his wok involving clinical and basic research at the University Hospital Ulm, Germany. Alexand

Gastroenterology